Daebongls.Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was KRW 24,834.56 million compared to KRW 24,232.34 million a year ago. Net income was KRW 970.86 million compared to KRW 5,970 million a year ago. Basic earnings per share from continuing operations was KRW 89 compared to KRW 545 a year ago. Diluted earnings per share from continuing operations was KRW 110. Basic earnings per share was KRW 89 compared to KRW 545 a year ago. Diluted earnings per share was KRW 110.
For the nine months, sales was KRW 0.00001 million compared to KRW 0.00001 million a year ago. Net income was KRW 10,843 million compared to KRW 8,199.41 million a year ago. Basic earnings per share from continuing operations was KRW 990 compared to KRW 749 a year ago. Diluted earnings per share from continuing operations was KRW 891. Basic earnings per share was KRW 990 compared to KRW 749 a year ago. Diluted earnings per share was KRW 891.
Daebongls. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The Company operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The Company distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.
